Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 26;19(23):15732.
doi: 10.3390/ijerph192315732.

Experiences of Hope after Treatment of Hepatitis C Infection-A Qualitative Study

Knut Tore Sælør  1 , Siv-Elin Leirvaag Carlsen  2 , Lars Thore Fadnes  3   4 , Lennart Lorås  5
Affiliations

Experiences of Hope after Treatment of Hepatitis C Infection-A Qualitative Study

Knut Tore Sælør et al. Int J Environ Res Public Health. .

Abstract

The aim of this study was to explore the experiences of hope people had after undergoing treatment for a hepatitis C virus infection (HCV). Between October 2019 and May 2020, 19 one-on-one interviews were conducted with people who inject drugs and had undergone HCV treatment. All participants had completed treatment and were documented as being virus-free. Data were audio recorded and then transcribed verbatim and analysed; a method inspired by reflexive thematic analysis. Those interviewed conveyed rich and nuanced descriptions of experiences of a life with HCV. Through the course of the analysis we developed four themes. The themes were formulated as metaphors aimed at capturing commonalities about how the participants seemed to "turn their gaze" after receiving HCV treatment: (1) turning their gaze backward; (2) turning their gaze inwards; (3) turning their gaze toward others and (4) turning their gaze forward. Participants' descriptions of their experiences relating to HCV were somewhat gloomy, and HCV treatment seemed to inspire hope and a brighter outlook on several areas of life.

Keywords: HCV treatment; hepatitis C; hope; recovery; substance abuse.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

See all similar articles

Cited by

References

    1. Đào G.J., Brunelle C., Speed D. Impact of substance use and mental health comorbidity on health care access in Canada. J. Dual Diagn. 2019;15:260–269. doi: 10.1080/15504263.2019.1634856. - DOI - PubMed
    1. Degenhardt L., Charlson F., Ferrari A., Santomauro D., Erskine H., Mantilla-Herrara A., Whiteford H., Leung J., Naghavi M., Griswold M. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5:987–1012. doi: 10.1016/S2215-0366(18)30337-7. - DOI - PMC - PubMed
    1. Degenhardt L., Peacock A., Colledge S., Leung J., Grebely J., Vickerman P., Stone J., Cunningham E.B., Trickey A., Dumchev K. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. Lancet Glob. Health. 2017;5:e1192–e1207. doi: 10.1016/S2214-109X(17)30375-3. - DOI - PMC - PubMed
    1. European Monitoring Centre for Drugs and Drug Addiction . Co-Morbid Substance Use and Mental Disorders in Europe: A Review of the Data. Publications Office of the European Union Luxembourg; Luxembourg: 2013.
    1. Castelnuovo E., Thompson-Coon J., Pitt M., Cramp M., Siebert U., Price A., Stein K. The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health Technol. Assess. 2006;10:iii–iv, ix. doi: 10.3310/hta10320. - DOI - PubMed

Publication types